285 related articles for article (PubMed ID: 31117836)
1. Antiproliferative activity and p53 upregulation effects of chalcones on human breast cancer cells.
Dos Santos MB; Bertholin Anselmo D; de Oliveira JG; Jardim-Perassi BV; Alves Monteiro D; Silva G; Gomes E; Lucia Fachin A; Marins M; de Campos Zuccari DAP; Octavio Regasini L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1093-1099. PubMed ID: 31117836
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and pro-apoptotic activities of 2'- and 4'-aminochalcones against tumor canine cells.
Santos MB; Pinhanelli VC; Garcia MAR; Silva G; Baek SJ; França SC; Fachin AL; Marins M; Regasini LO
Eur J Med Chem; 2017 Sep; 138():884-889. PubMed ID: 28738308
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
4. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of halogenated phenoxychalcones and their corresponding pyrazolines as cytotoxic agents in human breast cancer.
Halim PA; Hassan RA; Mohamed KO; Hassanin SO; Khalil MG; Abdou AM; Osman EO
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):189-201. PubMed ID: 34894967
[TBL] [Abstract][Full Text] [Related]
6. Chalcones incorporated pyrazole ring inhibit proliferation, cell cycle progression, angiogenesis and induce apoptosis of MCF7 cell line.
Mohamed MF; Mohamed MS; Fathi MM; Shouman SA; Abdelhamid IA
Anticancer Agents Med Chem; 2014; 14(9):1282-92. PubMed ID: 25323033
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of Aromatic Amide-Substituted Benzimidazole-Derived Chalcones. The Effect of Upregulating
Wu L; Yang Y; Wang Z; Wu X; Su F; Li M; Jing X; Han C
Molecules; 2020 Mar; 25(5):. PubMed ID: 32150865
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
Mohamed MF; Hassaneen HM; Abdelhamid IA
Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
[TBL] [Abstract][Full Text] [Related]
9. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
Ali NM; Akhtar MN; Ky H; Lim KL; Abu N; Zareen S; Ho WY; Alan-Ong HK; Tan SW; Alitheen NB; Ismail JB; Yeap SK; Kamarul T
Drug Des Devel Ther; 2016; 10():1897-907. PubMed ID: 27358555
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of novel α-substituted chalcones with potent anti-cancer activities and ability to overcome multidrug resistance.
Riaz S; Iqbal M; Ullah R; Zahra R; Chotana GA; Faisal A; Saleem RSZ
Bioorg Chem; 2019 Jun; 87():123-135. PubMed ID: 30884306
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
12. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of benzo[d][1,3]dioxol-5-yl chalcones as antiproliferating agents.
Kamal A; Balakrishna M; Loka Reddy V; Riyaz S; Bagul C; Satyanarayana BM; Venkateswar Rao J
Chem Biol Drug Des; 2015 Nov; 86(5):1267-84. PubMed ID: 26032623
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxic activities of some pyrazoline derivatives bearing phenyl pyridazine core as new apoptosis inducers.
George RF; Fouad MA; Gomaa IEO
Eur J Med Chem; 2016 Apr; 112():48-59. PubMed ID: 26874744
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway.
Marquina S; Maldonado-Santiago M; Sánchez-Carranza JN; Antúnez-Mojica M; González-Maya L; Razo-Hernández RS; Alvarez L
Bioorg Med Chem; 2019 Jan; 27(1):43-54. PubMed ID: 30482548
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic Effects on Breast Cancer Cell Lines of Chalcones Derived from a Natural Precursor and Their Molecular Docking Analysis.
Bustos L; Echiburú-Chau C; Castro-Alvarez A; Bradshaw B; Simirgiotis MJ; Mellado M; Parra C; Cuellar M
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889260
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of chalcones derived from 1-naphthylacetophenone and evaluation of their cytotoxic and apoptotic effects in acute leukemia cell lines.
Jacques AV; Stefanes NM; Walter LO; Perondi DM; Efe FDL; de Souza LFS; Sens L; Syracuse SM; de Moraes ACR; de Oliveira AS; Martins CT; Magalhaes LG; Andricopulo AD; Silva LO; Nunes RJ; Santos-Silva MC
Bioorg Chem; 2021 Nov; 116():105315. PubMed ID: 34496319
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells.
Shaik AB; Rao GK; Kumar GB; Patel N; Reddy VS; Khan I; Routhu SR; Kumar CG; Veena I; Chandra Shekar K; Barkume M; Jadhav S; Juvekar A; Kode J; Pal-Bhadra M; Kamal A
Eur J Med Chem; 2017 Oct; 139():305-324. PubMed ID: 28803046
[TBL] [Abstract][Full Text] [Related]
20. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
Ng HL; Chen S; Chew EH; Chui WK
Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
